The pharmacology of novel oral anticoagulants. - Wikidata - wikimedia - TriplyDB

The pharmacology of novel oral anticoagulants.

The pharmacology of novel oral anticoagulants.

http://www.wikidata.org/entity/Q38122099

about

Direct Oral Anticoagulants in Cirrhosis.Novel oral anticoagulants in non-valvular atrial fibrillation.Molecular recognition in chemical and biological systems.Novel anticoagulants: general overview and practical considerations for dental practitioners.Who, when, and how to reverse non-vitamin K oral anticoagulants.Novel anticoagulants - an update on the latest developments and management for clinicians treating patients on these drugs.Reversal agents of non-vitamin K dependent anticoagulants: a rapid review of the changing horizon.Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests.Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column

P2860

Q30277086-AE17A70F-03B2-40B6-BE3B-606071868FBB Q34666804-29CB6C29-BE23-4CCC-BC23-C70F8C1017CD Q38335784-2673DC58-AE2D-44B6-9968-2A34CF62524D Q38589533-D8441533-05D2-4AFC-826C-A7726EA73853 Q38655960-232EB127-7CDE-47E4-BE50-32B5C87C09FB Q38793747-B9960DB8-8CA5-4248-BCCC-93D9D8A5EDBD Q38970312-D0D857FC-4553-4AB0-BC4E-5CBA93EE3282 Q38980059-0B31BAC4-197B-4AEE-B636-F9708DE50D93 Q39251865-737A3323-7A63-418F-85CF-4E1197490062 Q49647319-5A6AE89D-14D5-4F6A-A19F-41EBB12A3A64 Q51088831-A9BF0DEC-7E86-4579-BB5D-9EDB6756B378 Q55442446-85C380D7-53E2-44A0-A554-3F15B62599F1 Q57807139-98A3543B-5856-47EF-A6E5-D36EB82EA4DA Q58180540-C5DF627C-2291-4EC5-AC31-E240FACACD18

P2860

The pharmacology of novel oral anticoagulants.

http://www.wikidata.org/entity/Q38122099

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The pharmacology of novel oral anticoagulants.

@en

type

label

The pharmacology of novel oral anticoagulants.

@en

prefLabel

The pharmacology of novel oral anticoagulants.

@en

P1433

Q38122099-A961F193-0116-42AA-AD39-71DA700F3662

P1476

Q38122099-BD6E605A-CB1E-476B-AEFC-C474A1C01821

P2093

Q38122099-0C542F2C-11B8-4137-991E-9E435295FED3

Q38122099-382AFF7C-7601-415F-AF2B-A8E84C26EC8A

P2860

Q38122099-02092071-B1A0-4D5E-8574-98499E0BA45E

Q38122099-025ACFD7-0435-48DA-8E48-3ACB9D78A122

Q38122099-02D76C87-42BA-4D12-983F-059D85310687

Q38122099-04C74992-CB24-4279-9CEB-B91B70F1815C

Q38122099-04FE5F2D-12CA-4166-9F90-97CED013F9AD

Q38122099-05710962-1194-42EE-853F-181F8E1BAB3A

Q38122099-05ECE643-EF3D-429E-8F0B-5AE102475C5F

Q38122099-06A4864D-4A82-45E7-8D39-3D1ACA3C5898

Q38122099-087F7526-AF86-491F-8F69-80587AA27BF3

Q38122099-0AA1F4FF-275E-4DBD-8B57-CB3E9001E0C4

P2888

Q38122099-50C78E06-63DD-4176-969F-8915299C9E02

P304

Q38122099-A750D357-6A4E-41CA-8535-E5AE689B6519

P31

Q38122099-C090A19C-A269-41F6-BA6F-30EBFA203DD6

P356

Q38122099-186172E0-77E3-4319-BCA2-37F0D1CBD17E

P433

Q38122099-E4903853-880E-4206-A35E-0F597284A96F

P478

Q38122099-E8A7FDA8-8CA7-44A6-BB30-B5E6FA3896C0

P577

Q38122099-EDFC34D4-9184-40B5-AF07-B9B9C8E97706

P698

Q38122099-A391F111-F129-4914-8532-AAB0286A8D94

P921

Q38122099-11244F19-33DE-4097-9DBA-893BECFC1929

Q38122099-C2CA4A7C-03FF-4023-842F-B9E7CD7E1A87

P356

S11239-013-0967-Z

P1433

Journal of Thrombosis and Thrombolysis

P1476

The pharmacology of novel oral anticoagulants.

@en

P2093

Richard C Becker

http://www.w3.org/2001/XMLSchema#string

Tracy A DeWald

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetics, pharmacogenomics, and individualized medicine

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Structure-based design of novel potent nonpeptide thrombin inhibitors

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dose adjustment in patients with liver disease

Dabigatran versus warfarin in patients with atrial fibrillation

New oral anticoagulants in atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database

P2888

s11239-013-0967-z

P304

217-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-013-0967-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23860880

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation